中华消化杂志
中華消化雜誌
중화소화잡지
Chinese Journal of Digestion
2013年
3期
187-190
,共4页
孙艳%盛春华%文大成%李玉林%迟宝荣
孫豔%盛春華%文大成%李玉林%遲寶榮
손염%성춘화%문대성%리옥림%지보영
结直肠肿瘤%干细胞%lgr5%基因表达
結直腸腫瘤%榦細胞%lgr5%基因錶達
결직장종류%간세포%lgr5%기인표체
Colorectal neoplasms%Stem cells%lgr5%Gene expression
目的 探讨人结直肠癌组织及外周血中干细胞标志物富含亮氨酸重复单位的G蛋白耦联受体5(lgr5)基因的表达及其与临床病理特征间的关系.方法 采用SYBR Green实时定量PCR方法检测27份结直肠癌组织及配对的正常组织中、1 7例患者及8名健康对照者外周血中lgr5mRNA的表达.应用Wilcoxon秩和检验分析lgr5 mRNA在不同组织间、临床病理参数之间的表达差异.结果 结直肠癌组织中lgr5 mRNA表达水平为1.000(0.012,496.353),高于配对正常组织的0.147(0.004,73.002),差异有统计学意义(Z=8.029,P<0.01).结直肠癌患者外周血中lgr5mRNA表达水平为0.742(0.077,456.566),高于健康对照组的0.104(0.034,0.274),差异有统计学意义(Z=2.048,P<0.05).结直肠癌组织lgr5 mRNA在不同性别、年龄、肿瘤原发部位、肿瘤大小、组织学类型组间表达差异均无统计学意义(P均>0.05),但有淋巴结转移组lgr5 mRNA表达高于无淋巴结转移组,差异有统计学意义(Z=2.066,P<0.05).结论 lgr5在结直肠癌组织及外周血中的表达上调可能参与了结直肠癌的生长及转移.
目的 探討人結直腸癌組織及外週血中榦細胞標誌物富含亮氨痠重複單位的G蛋白耦聯受體5(lgr5)基因的錶達及其與臨床病理特徵間的關繫.方法 採用SYBR Green實時定量PCR方法檢測27份結直腸癌組織及配對的正常組織中、1 7例患者及8名健康對照者外週血中lgr5mRNA的錶達.應用Wilcoxon秩和檢驗分析lgr5 mRNA在不同組織間、臨床病理參數之間的錶達差異.結果 結直腸癌組織中lgr5 mRNA錶達水平為1.000(0.012,496.353),高于配對正常組織的0.147(0.004,73.002),差異有統計學意義(Z=8.029,P<0.01).結直腸癌患者外週血中lgr5mRNA錶達水平為0.742(0.077,456.566),高于健康對照組的0.104(0.034,0.274),差異有統計學意義(Z=2.048,P<0.05).結直腸癌組織lgr5 mRNA在不同性彆、年齡、腫瘤原髮部位、腫瘤大小、組織學類型組間錶達差異均無統計學意義(P均>0.05),但有淋巴結轉移組lgr5 mRNA錶達高于無淋巴結轉移組,差異有統計學意義(Z=2.066,P<0.05).結論 lgr5在結直腸癌組織及外週血中的錶達上調可能參與瞭結直腸癌的生長及轉移.
목적 탐토인결직장암조직급외주혈중간세포표지물부함량안산중복단위적G단백우련수체5(lgr5)기인적표체급기여림상병리특정간적관계.방법 채용SYBR Green실시정량PCR방법검측27빈결직장암조직급배대적정상조직중、1 7례환자급8명건강대조자외주혈중lgr5mRNA적표체.응용Wilcoxon질화검험분석lgr5 mRNA재불동조직간、림상병리삼수지간적표체차이.결과 결직장암조직중lgr5 mRNA표체수평위1.000(0.012,496.353),고우배대정상조직적0.147(0.004,73.002),차이유통계학의의(Z=8.029,P<0.01).결직장암환자외주혈중lgr5mRNA표체수평위0.742(0.077,456.566),고우건강대조조적0.104(0.034,0.274),차이유통계학의의(Z=2.048,P<0.05).결직장암조직lgr5 mRNA재불동성별、년령、종류원발부위、종류대소、조직학류형조간표체차이균무통계학의의(P균>0.05),단유림파결전이조lgr5 mRNA표체고우무림파결전이조,차이유통계학의의(Z=2.066,P<0.05).결론 lgr5재결직장암조직급외주혈중적표체상조가능삼여료결직장암적생장급전이.
Objective To investigate the expression of stem cell marker leucine-rich repeat containing G protein coupled receptor 5 (lgr5) gene in human colorectal cancer tissues and peripheral blood and its correlation with clinical pathological characteristics.Methods The expression of lgr5 at mRNA level was detected by SYBR Green quantitative real-time polymerase chain reaction (PCR) in 27 human colorectal cancer tissues and corresponding non-cancerous tissues as well as in peripheral blood of 17 patients and eight healthy controls.The differences of lgr5 mRNA expression in different tissues and clinical pathology parameters were analyzed by Wilcoxon test.Results The expression of lgr5 at mRNA level in colorectal cancer tissues was 1.000 (0.012,496.353),which was higher than that of corresponding non-cancerous tissues 0.147 (0.004,73.002),the difference was statistically significant (Z=8.029,P<0.01).The lgr5 expression at mRNA level in peripheral blood of colorectal cancer patients was 0.742 (0.077,456.566),which was higher than that of healthy controls 0.104 (0.034,0.274) and the difference was statistically significant (Z=2.048,P<0.05).There were no statistically significant differences between lgr5 expression at mRNA level and gender,age,primary location of tumor,tumor size and pathological type (all P>0.05).However,the expression of lgr5 at mRNA level in group with lymph node metastasis was higher than that in group without lymph node metastasis (Z=2.066,P<0 05).Conclusion The up-regulation of lgr5 gene expression in colorectal cancer tissues and peripheral blood may be involved in the growth and metastasis of colorectal cancer.